![Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials - The Lancet Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials - The Lancet](https://www.thelancet.com/cms/attachment/2001010417/2003789589/gr1.gif)
Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials - The Lancet
![Statin-Related New-Onset Diabetes Appears Driven by Increased Insulin Resistance: Are There Clinical Implications? | Arteriosclerosis, Thrombosis, and Vascular Biology Statin-Related New-Onset Diabetes Appears Driven by Increased Insulin Resistance: Are There Clinical Implications? | Arteriosclerosis, Thrombosis, and Vascular Biology](https://www.ahajournals.org/cms/asset/7e031595-0e91-4054-a3ed-8b8249694ef6/atvbaha.121.316893.fig01.jpg)
Statin-Related New-Onset Diabetes Appears Driven by Increased Insulin Resistance: Are There Clinical Implications? | Arteriosclerosis, Thrombosis, and Vascular Biology
![Understanding How Statins Prevent Cardiovascular Disease but Increase Diabetes Risk | Stanford Cardiovascular Institute | Stanford Medicine Understanding How Statins Prevent Cardiovascular Disease but Increase Diabetes Risk | Stanford Cardiovascular Institute | Stanford Medicine](http://med.stanford.edu/content/dam/sm/cvi/images/graphics/knowles-graphic.jpg)
Understanding How Statins Prevent Cardiovascular Disease but Increase Diabetes Risk | Stanford Cardiovascular Institute | Stanford Medicine
![Time-varying and dose-dependent effect of long-term statin use on risk of type 2 diabetes: a retrospective cohort study | Cardiovascular Diabetology | Full Text Time-varying and dose-dependent effect of long-term statin use on risk of type 2 diabetes: a retrospective cohort study | Cardiovascular Diabetology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12933-020-01037-0/MediaObjects/12933_2020_1037_Fig2_HTML.png)
Time-varying and dose-dependent effect of long-term statin use on risk of type 2 diabetes: a retrospective cohort study | Cardiovascular Diabetology | Full Text
![Comparison of the efficacy and safety of rosuvastatin versus atorvastatin in reduction of low density lipoprotein cholesterol in patients of type 2 diabetes mellitus with dyslipidemia | Semantic Scholar Comparison of the efficacy and safety of rosuvastatin versus atorvastatin in reduction of low density lipoprotein cholesterol in patients of type 2 diabetes mellitus with dyslipidemia | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/b6d5b5912f98294aa4a4ccfa1d64a883babac4f4/3-Figure1-1.png)
Comparison of the efficacy and safety of rosuvastatin versus atorvastatin in reduction of low density lipoprotein cholesterol in patients of type 2 diabetes mellitus with dyslipidemia | Semantic Scholar
![Time‐ and Dose‐Dependent Association of Statin Use With Risk of Clinically Relevant New‐Onset Diabetes Mellitus in Primary Prevention: A Nationwide Observational Cohort Study | Journal of the American Heart Association Time‐ and Dose‐Dependent Association of Statin Use With Risk of Clinically Relevant New‐Onset Diabetes Mellitus in Primary Prevention: A Nationwide Observational Cohort Study | Journal of the American Heart Association](https://www.ahajournals.org/cms/asset/dac8d277-379e-47e5-ab84-580b05e348a4/jah33974-fig-0002.png)
Time‐ and Dose‐Dependent Association of Statin Use With Risk of Clinically Relevant New‐Onset Diabetes Mellitus in Primary Prevention: A Nationwide Observational Cohort Study | Journal of the American Heart Association
![Statin use and risk of developing diabetes: results from the Diabetes Prevention Program | BMJ Open Diabetes Research & Care Statin use and risk of developing diabetes: results from the Diabetes Prevention Program | BMJ Open Diabetes Research & Care](https://drc.bmj.com/content/bmjdrc/5/1/e000438/F1.large.jpg)
Statin use and risk of developing diabetes: results from the Diabetes Prevention Program | BMJ Open Diabetes Research & Care
![Risk of new-onset diabetes and cardiovascular risk reduction from high-dose statin therapy in pre-diabetics and non-pre-diabetics: an analysis from TNT and IDEAL. | Semantic Scholar Risk of new-onset diabetes and cardiovascular risk reduction from high-dose statin therapy in pre-diabetics and non-pre-diabetics: an analysis from TNT and IDEAL. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/7d4a46105d0e1898614011a7da68da86f7a56f62/2-Figure1-1.png)